Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients

Martin-du-pan, Sophie Marie Catherine; Scherer, Almut; Gabay, Cem; Finckh, Axel

doi:10.1136/annrheumdis-2011-200882

Scientific article

English

Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients

ContributorsMartin-du-pan, Sophie Marie Catherine; Scherer, Almut; Gabay, Cem; Finckh, Axel

Published inAnnals of the rheumatic diseases, vol. 71, no. 6, p. 997-999

Publication date2012

Abstract

After inadequate response to an antitumour necrosis factor (aTNF) agent for treatment of rheumatoid arthritis (RA), rheumatologists can choose an alternative aTNF or a biological agent with another mode of action (non-aTNF biological (non-aTNF-Bio)).

Keywords

Adult
Aged
Antibodies, Monoclonal, Humanized/administration & dosage/pharmacokinetics
Antirheumatic Agents/administration & dosage/pharmacokinetics
Arthritis, Rheumatoid/drug therapy
Female
Glucocorticoids/administration & dosage/pharmacokinetics
Humans
Immunoconjugates/administration & dosage/pharmacokinetics
Isoxazoles/administration & dosage/pharmacokinetics
Male
Methotrexate/administration & dosage/pharmacokinetics
Middle Aged
Prednisone/administration & dosage/pharmacokinetics
Proportional Hazards Models
Registries
Remission Induction
Treatment Outcome
Tumor Necrosis Factor-alpha/antagonists & inhibitors

Affiliation

Faculté de médecine / Section de médecine clinique / Département de médecine

Research group

Mécanisme de l'inflammation articulaire (44)

Citation (ISO format)

MARTIN-DU-PAN, Sophie Marie Catherine et al. Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients. In: Annals of the rheumatic diseases, 2012, vol. 71, n° 6, p. 997–999. doi: 10.1136/annrheumdis-2011-200882

Article (Published version)

Identifiers

PID : unige:32505
DOI : 10.1136/annrheumdis-2011-200882
PMID : 22294628

ISSN of the journal0003-4967

590views

0downloads

Creation11/15/2013 4:23:00 PM

First validation11/15/2013 4:23:00 PM

Update time03/14/2023 8:45:48 PM

Status update03/14/2023 8:45:47 PM

Last indexation01/16/2024 8:38:02 AM

Archive ouverte UNIGE

Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients

After inadequate response to an antitumour necrosis factor (aTNF) agent for treatment of rheumatoid arthritis (RA), rheumatologists can choose an alternative aTNF or a biological agent with another mode of action (non-aTNF biological (non-aTNF-Bio)).

Technical informations